Murphy, Michael P.
Hartley, Richard C.
Article History
First Online: 5 November 2018
Competing interests
: M.P.M. has a financial interest in Antipodean Pharmaceuticals, a company that is developing mitochondria-targeted therapies. M.P.M. and R.C.H. also hold patents in the area of mitochondrial therapies. In addition, M.P.M. consults for Novintum Biotechnology, Cayman Chemicals and Takeda Pharmaceuticals, and R.C.H. consults for Cayman Chemicals.